Edwards Lifesciences (EW) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Powered by 
Analysis
Edwards Lifesciences (EW) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.08 Bn | 178.48 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.33 Bn | 119.11 Bn | 1.96 Bn |
| 3 | Medtronic | 118.50 Bn | 109.68 Bn | 6.34 Bn |
| 4 | Stryker | 106.32 Bn | 102.85 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.81 Bn | 66.27 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn |
| 7 | Alcon | 34.03 Bn | 32.57 Bn | 1.68 Bn |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -36.59% |
| Mar 31, 2026 | 317.43% |
| Dec 31, 2025 | -68.58% |
| Sep 30, 2025 | -12.43% |
| Jun 30, 2025 | -6.99% |
| Mar 31, 2025 | -7.26% |
| Dec 31, 2024 | -87.48% |
| Sep 30, 2024 | 740.93% |
| Jun 30, 2024 | 3.99% |
| Mar 31, 2024 | -5.06% |
| Dec 31, 2023 | -3.65% |
| Sep 30, 2023 | 24.46% |
| Jun 30, 2023 | -9.46% |
| Mar 31, 2023 | -14.53% |
| Dec 31, 2022 | 15.98% |
| Sep 30, 2022 | -15.48% |
| Jun 30, 2022 | 8.78% |
| Mar 31, 2022 | 11.42% |
| Dec 31, 2021 | -1.41% |
| Sep 30, 2021 | -30.52% |